We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nuformix Plc | LSE:NFX | London | Ordinary Share | GB00BYW79Y38 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.185 | 0.17 | 0.20 | 0.19 | 0.19 | 0.19 | 1,431,108 | 16:35:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -859k | -0.0012 | -1.58 | 1.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
25/11/2019 17:34 | Well my prediction was correct and closed my short today at 7.5p as was not expecting the update contained within the RNS. This actually puts a totally different perspective on the value of Nuformix. | galaxy enforcer | |
25/11/2019 16:40 | Wise words Jak, thats why I was buying through 2018 and have a weighted average of 2.6p, time has shown that I've been correct in my decision. Keep trying, you'll learn one day. | soupdragon55 | |
25/11/2019 16:22 | It will be interesting to see if larger holders will be coming onboard now through the broker. Cash is fine and the chinese side of things is pending so it would be an attractive sell for getting bigger investors on board. | soupdragon55 | |
25/11/2019 16:20 | Silly silly silly sellers still people think jobbing in and out for 20pence is a good strategy Oh who is me they will truly regret that one of these days | whatsthepoint | |
25/11/2019 16:19 | Well maybe my tome has arrived soup ?? | whatsthepoint | |
25/11/2019 16:14 | Love this post from only two hours ago. JakNife - 25 Nov 2019 - 13:58:16 - 3796 of 3842 Nuformix plc - NFX Whatsthepoint, "The smart money is buying this" You have NEVER been the "smart money" in your entire life! JakNife | soupdragon55 | |
25/11/2019 16:09 | can see this hitting no1 on riser board into close and HUGE gap up tomm | ssrover | |
25/11/2019 16:07 | NFX going for a big finish... will be a gapper up tomorrow | ssrover | |
25/11/2019 15:37 | Agreement in writing for owed money worth its weight in gold, sounds like payment deferred while additional collaborations are discussed all part of the final agreement. An impressive update, this could go a lot higher imo dyor ofc. | rathean | |
25/11/2019 15:27 | Justin Waite @SharePickers · 3m Nuformix #NFX up over 20%, bullish engulfing candle, RSI above 50 and headed towards 60: hxxps://voxmarkets.c | ssrover | |
25/11/2019 15:24 | Who has the cheque Book ready ;) Great hand Dan holds now. This was very strategic indeed and will be paid in multiples to share holders very soon. This should be at 15p now that’s settled the deals will be a little quicker coming fwd imo ;) | ssrover | |
25/11/2019 15:14 | Really still so surprised we still have small sellers when are people going to realise run your winners sell your losers Selling these too soon will seriously damage your wealth | whatsthepoint | |
25/11/2019 15:09 | going crazy.. can see it hitting 18-20p this week | ssrover | |
25/11/2019 15:08 | JAK you still watching. | whatsthepoint | |
25/11/2019 15:04 | BOOOOOOOMMMMMM | whatsthepoint | |
25/11/2019 15:04 | Yes this was close to sign off back in the summer before the change in regulation from Chinese but it will only accelerate a move to a more cohesive Chinese drugs market Look into Sinopharma they are accruing smaller players they may gob up Yatai then we are partnered with state owned big Pharma That's the big league Dyor. And from this morning RNS deals being negotiated with US We will be on all big Pharma Radar now Ebers going great guns NXP002 going really great guns multiple partners fighting over that one And now NXP004 which is in cancer drug market so will be massive When the dust settles and the market assess today's news we will start the move to new highs With less weak holders the resistance will be minor | whatsthepoint | |
25/11/2019 15:01 | Podcast confirms that Eber revenue fully covers operating costs so the placing should be fully invested back into the business rather than be used to pay wages. Market reaction seems to support that.Re: NXP002, sounds like the money may be needed to push ahead with the inhaled delivery solution requured to treat the fibrosis related cough symptoms. This may be needed to satisfy a condition for a prospective deal?There do appear to be regulatory problems with the Chinese deal though. Those are not always easy to get around | for fx sake | |
25/11/2019 14:57 | Interesting part of the interview around the china payment, increasing it to 3m and increasing their involvment, setting up a joint venture, just waiting for regulatory clearance. | soupdragon55 | |
25/11/2019 14:57 | Number 4 on the riser board will we finish top still a possibility as more listen to Podcast | whatsthepoint | |
25/11/2019 14:53 | Sellers absorbed now over 10p into the close More will listen to pod cast over the evening and will all want a slice | whatsthepoint | |
25/11/2019 14:47 | Don't be out when the deal news starts to flow | whatsthepoint | |
25/11/2019 14:47 | Don't be fooled into giving away your golden tickets. This is going to do a VRS type rally over the coming months | whatsthepoint | |
25/11/2019 14:43 | Well you must be deaf | whatsthepoint |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions